New Key Statistics Module, Z-Score and F-Score
NAS:IONS Key Ratios
Market Cap $ M | 6,114.46 |
Enterprise Value $ M | 5,423.81 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 21.42 |
Price/Sales | 6.94 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 813.00 |
EPS (TTM) $ | -2.52 |
Beneish M-Score | -2.5 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -20.24 |
EV-to-EBITDA | -22.09 |
PEG | -- |
Shares Outstanding M | 157.71 |
Net Margin (%) | -44.96 |
Operating Margin % | -44.87 |
Pre-tax Margin (%) | -43.33 |
Quick Ratio | 7.51 |
Current Ratio | 7.61 |
ROA % (ttm) | -12.74 |
ROE % (ttm) | -108.17 |
ROIC % (ttm) | -67.50 |
Dividend Yield % | -- |
Altman Z-Score | 1.33 |
IONS Number of Guru Trades
IONS Volume of Guru Trades
Gurus Latest Trades with NAS:IONS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:IONS is held by these investors
Total 4
Ionis Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:IONS
Total 0- 1